semaglutide euglycemic dka diabetic ketoacidosis in the era of SGLT-2 inhibitors From Sweet to Sour: SGLT-2-Inhibitor-Induced

The critical difference: Mounjaro (tirzepatide) is FDA approved and available by prescription today, while Retatrutide remains in Phase 3 clinical trials with projected approval in late 2026 to early 2027

And the same goes for this type of statement

The most common side effects of L carnitine injection are mild and temporary

Both drugs can independently cause tachycardia (increased heart rate), and together they may compound this effect, increasing the risk of arrhythmias and other cardiac events

The endosomal cAMP hypothesis that receptor internalization to Rab5 endosomes generates a second-wave cAMP pulse that enhances insulin secretion has been a prominent mechanistic framework